The FBA2 antibody is a polyclonal reagent raised against a synthetic peptide corresponding to the FBA2 protein (UniProt ID: AT4G38970 in Arabidopsis thaliana). FBA2 belongs to the aldolase family, which catalyzes the reversible cleavage of fructose-1,6-bisphosphate into glyceraldehyde-3-phosphate and dihydroxyacetone phosphate in the Calvin cycle .
Function: Critical for photosynthetic carbon assimilation and glycolysis .
Localization: Chloroplast stroma.
Conservation: Widely conserved across angiosperms, enabling cross-species reactivity .
The FBA2 antibody has been employed in:
Immunoblotting: Detecting FBA2 expression in plant tissue lysates.
Subcellular Localization Studies: Confirming chloroplast-specific expression.
Functional Genomics: Investigating FBA2 knockout phenotypes in Arabidopsis.
Limitations: No peer-reviewed publications directly using this antibody were identified in the provided sources.
Opportunities:
Characterizing FBA2’s role in stress responses (e.g., drought, salinity).
Engineering crops with altered aldolase activity for improved yield.
FBA2 antibody specifically recognizes the probable fructose-bisphosphate aldolase 2 protein located in chloroplasts, with the primary target being Arabidopsis thaliana (AT4G38970). This antibody demonstrates significant cross-reactivity with homologous proteins in several plant species including Brassica napus, Brassica rapa, Solanum lycopersicum, Gossypium raimondii, Vitis vinifera, Nicotiana tabacum, Solanum tuberosum, Glycine max, Medicago truncatula, Spinacia oleracea, Populus trichocarpa, and Cucumis sativus . The extensive cross-reactivity makes this antibody particularly valuable for comparative studies across different plant species. The sequence of the synthetic peptide used for immunization is 100% homologous with the sequence in FBA1 (AT2G21330), which researchers must consider when designing experiments to distinguish between these two related aldolases . FBA2 plays a critical role in the Calvin cycle within chloroplasts, making this antibody an essential tool for investigating photosynthetic carbon metabolism in plants.
The FBA2 antibody is typically supplied in lyophilized form and requires careful handling to maintain its functionality and specificity. Researchers should store the lyophilized antibody in a manual defrost freezer and conscientiously avoid repeated freeze-thaw cycles that can degrade the antibody's structure and reduce its effectiveness . Upon receipt, the product is shipped at 4°C but should be immediately transferred to the recommended storage temperature to preserve its activity . For reconstitution, sterile techniques should be employed using appropriate buffers, typically phosphate-buffered saline with or without carrier proteins depending on the intended application. The reconstituted antibody should be aliquoted into single-use volumes to minimize freeze-thaw cycles and maintain consistency across experiments. Proper labeling of aliquots with date of reconstitution, concentration, and any additives is essential for tracking antibody age and potential changes in performance over time. When handling the antibody, researchers should wear appropriate personal protective equipment to prevent contamination and maintain product integrity.
Verifying antibody specificity is crucial for obtaining reliable results, particularly when working with proteins that have high sequence homology like FBA1 and FBA2. Researchers should first perform Western blot analysis using recombinant FBA2 protein as a positive control and extract from FBA2 knockout plants as a negative control to confirm target specificity. Similar to strategies used with other antibodies, epitope mapping can be employed to precisely identify the binding region of the FBA2 antibody, which can help predict and understand potential cross-reactivity issues . Competition assays, where pre-incubation of the antibody with purified target antigen blocks subsequent binding, provide another method to confirm specificity . Additionally, researchers should validate specificity in their particular experimental conditions by performing immunoprecipitation followed by mass spectrometry to identify all proteins captured by the antibody. For plant species beyond Arabidopsis, sequence alignment analysis comparing the immunogen sequence with the corresponding region in the target species can help predict cross-reactivity potential. Multiple antibody validation approaches should be combined to build a comprehensive profile of the antibody's specificity and limitations.
When using FBA2 antibody for Western blot applications, researchers should begin with sample preparation by extracting proteins from plant tissues using a buffer containing protease inhibitors to prevent degradation of the target protein. Similar to the protocols established for other plant antibodies, protein samples (20-50 μg) should be separated on 10-12% SDS-PAGE gels followed by transfer to nitrocellulose or PVDF membranes . Blocking should be performed using 5% non-fat dry milk or 3-5% BSA in TBST (Tris-buffered saline with 0.1% Tween-20) for 1 hour at room temperature. The optimal primary antibody dilution for FBA2 typically ranges from 1:1000 to 1:5000 in blocking buffer, with incubation overnight at 4°C for maximum sensitivity and specificity. Following primary antibody incubation, membranes should be washed thoroughly (3-5 times for 5-10 minutes each) with TBST to remove unbound antibody before incubation with an appropriate HRP-conjugated secondary antibody. For enhanced sensitivity, researchers can employ chemiluminescent detection systems, with exposure times optimized based on signal strength. To account for the cross-reactivity with FBA1, researchers should include appropriate controls and potentially use complementary approaches such as immunoprecipitation followed by mass spectrometry to confirm band identity.
For immunolocalization of FBA2 in plant tissues, researchers should employ fixation protocols that preserve both tissue architecture and antigen accessibility. Tissues should be fixed in 4% paraformaldehyde in PBS with vacuum infiltration to ensure complete penetration, followed by careful embedding in either paraffin for light microscopy or appropriate resins for electron microscopy. Drawing from established methodologies for chloroplast proteins, antigen retrieval steps may be necessary to expose epitopes masked during fixation, with citrate buffer (pH 6.0) being commonly effective . When preparing sections, thickness should be optimized (typically 5-10 μm for light microscopy) to balance structural integrity with antibody penetration. Blocking should be performed with 2-5% normal serum from the species in which the secondary antibody was raised, supplemented with 0.1-0.3% Triton X-100 to enhance membrane permeability. FBA2 antibody should be applied at dilutions ranging from 1:100 to 1:500, with overnight incubation at 4°C to maximize binding specificity. For visualization, fluorophore-conjugated secondary antibodies are recommended, with DAPI or other nuclear stains serving as counterstains to provide cellular context. Confocal microscopy with Z-stack acquisition can provide three-dimensional localization information, particularly valuable for studying chloroplast distribution patterns under different physiological conditions.
Differentiating between FBA1 and FBA2 requires careful experimental design due to their high sequence homology, particularly since the synthetic peptide used for FBA2 antibody immunization shares 100% homology with the sequence in FBA1 . Researchers should employ a multi-faceted approach beginning with genetic resources, using fba1 and fba2 knockout or knockdown lines as critical controls to confirm antibody specificity. Competitive binding assays using purified recombinant FBA1 and FBA2 proteins can help determine the relative affinity of the antibody for each target. Similar to epitope mapping approaches used for other antibodies, researchers can develop a series of peptides with sequence variations to identify residues critical for antibody binding, which may reveal subtle differences in recognition patterns between FBA1 and FBA2 . Immunoprecipitation followed by mass spectrometry analysis can provide definitive identification of the captured proteins. For subcellular localization studies, researchers can take advantage of the different compartmentalization patterns, as FBA2 is predominantly chloroplastic while FBA1 may have different distribution patterns. Quantitative Western blotting comparing wild-type, fba1, and fba2 mutant plants can also help establish the contribution of each protein to the observed signal.
FBA2 antibody serves as a powerful tool for investigating chloroplastic fructose-bisphosphate aldolase responses to environmental stressors such as drought, high light, temperature extremes, or nutrient limitation. Researchers should design time-course experiments sampling plant tissues at strategic intervals after stress application to capture both rapid responses and acclimation dynamics. Western blot analysis using FBA2 antibody can quantify changes in protein abundance, while fractionation studies can reveal potential stress-induced relocalization between chloroplast subcompartments. To gain mechanistic insights, researchers should complement protein-level analyses with transcript quantification (qRT-PCR or RNA-seq) and enzyme activity assays to distinguish between transcriptional, translational, and post-translational regulatory mechanisms. Co-immunoprecipitation using FBA2 antibody followed by mass spectrometry can identify stress-specific interaction partners that may regulate enzyme activity or localization. For comprehensive understanding, these approaches should be integrated with metabolomic analyses targeting Calvin cycle intermediates and end products to correlate FBA2 dynamics with metabolic flux alterations. Additionally, comparing responses between wild-type plants and genetic variants with altered FBA2 expression can elucidate the specific contribution of this enzyme to stress adaptation mechanisms in photosynthetic metabolism.
When confronted with contradictory findings using FBA2 antibody, researchers should implement a systematic troubleshooting approach that addresses both technical and biological variables. Begin by validating antibody performance through Western blot analysis of recombinant FBA2 protein and comparing results from multiple antibody lots to identify potential batch-to-batch variations. Similar to approaches used for other antibodies with complex target recognition patterns, researchers should test different protein extraction methods to ensure complete solubilization of membrane-associated pools of the target protein that might be missed using standard protocols . Carefully examine experimental conditions that might affect FBA2 expression or post-translational modifications, such as plant developmental stage, growth conditions, time of day (particularly important for photosynthetic enzymes), and stress status. Employ complementary techniques such as enzyme activity assays, transcript analysis, and mass spectrometry-based proteomics to corroborate antibody-based findings. Consider the potential for off-target binding by performing immunoprecipitation followed by mass spectrometry in both wild-type and fba2 mutant backgrounds to identify all proteins recognized by the antibody under your specific experimental conditions. Additionally, involve multiple researchers in performing critical experiments to eliminate unconscious biases in technique that might influence outcomes.
A comprehensive study of carbon fixation pathways requires integration of antibody-based FBA2 detection with complementary methodologies across multiple scales of biological organization. Researchers should combine FBA2 antibody-based protein quantification and localization with enzyme activity assays that measure the conversion of fructose 1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. This integrated approach, similar to strategies employed for studying other metabolic pathways, allows correlation between protein abundance and functional activity . Metabolic flux analysis using stable isotope labeling (13C) can track carbon movement through the Calvin cycle, while metabolomics approaches can quantify pathway intermediates and end products to identify potential metabolic bottlenecks. At the regulatory level, researchers should examine transcriptional control using RNA-seq or qRT-PCR, post-translational modifications using phosphoproteomic approaches, and protein-protein interactions using co-immunoprecipitation with FBA2 antibody followed by mass spectrometry. For spatial context, combine immunolocalization of FBA2 with fluorescent protein tagging of other Calvin cycle enzymes to visualize potential metabolic channeling within chloroplasts. Mathematical modeling incorporating data from these multiple approaches can provide systems-level insights into Calvin cycle regulation and identify key control points under different environmental conditions.
When encountering weak or inconsistent signals with FBA2 antibody in immunoblotting, researchers should implement a systematic optimization strategy. First, evaluate protein extraction methods, ensuring complete extraction of chloroplast proteins by including appropriate detergents (0.1-1% Triton X-100 or 0.5% sodium deoxycholate) and mechanical disruption techniques such as bead-beating or sonication. Fresh preparation of samples and addition of reducing agents like dithiothreitol (DTT) or β-mercaptoethanol can preserve epitope accessibility by preventing disulfide bond formation. Similar to optimization strategies for other challenging antibodies, researchers should test multiple blocking agents (5% milk, 3-5% BSA, or commercial blocking solutions) as certain blockers may interfere with antibody-epitope interactions . Optimize antibody concentration through titration experiments, typically testing dilutions from 1:500 to 1:5000, while also extending incubation times (overnight at 4°C) to enhance signal strength. Signal amplification systems such as enhanced chemiluminescence (ECL) Plus or femto-sensitivity ECL reagents can dramatically improve detection of low-abundance targets. For particularly challenging samples, consider concentrating the target protein through immunoprecipitation prior to Western blotting or using gradient gels to improve separation of proteins with similar molecular weights. Additionally, experiment with different membrane types (PVDF versus nitrocellulose) and transfer conditions (wet versus semi-dry) as these parameters can significantly impact protein binding and subsequent detection sensitivity.
Minimizing background when working with FBA2 antibody requires attention to multiple experimental parameters across different applications. For Western blotting, thorough blocking with 5% non-fat dry milk or 3-5% BSA in TBST for 1-2 hours at room temperature can effectively reduce non-specific binding. Extended and rigorous washing steps between antibody incubations (at least 3 washes of 10 minutes each with TBST) remove unbound antibody that contributes to background. Following approaches established for other plant antibodies, researchers should optimize antibody dilution through systematic titration experiments to identify the concentration that maximizes specific signal while minimizing background . For immunohistochemistry applications, pre-adsorption of the antibody with plant extract from fba2 knockout plants can remove potentially cross-reactive antibodies within the polyclonal mixture. Autofluorescence, particularly problematic in plant tissues due to chlorophyll and phenolic compounds, can be reduced by short incubations in sodium borohydride (0.1% in PBS) or through specialized quenching reagents. Using highly cross-adsorbed secondary antibodies pre-cleared against plant proteins can significantly reduce non-specific binding. For immunoprecipitation applications, including pre-clearing steps with protein A/G beads alone before adding the specific antibody helps eliminate proteins that bind non-specifically to the beads. Additionally, including detergents such as 0.1% Tween-20 or 0.1% Triton X-100 in wash buffers can effectively reduce hydrophobic interactions that contribute to background.
Using FBA2 antibody across different plant species requires careful consideration of evolutionary conservation, experimental validation, and protocol adaptation. Researchers should begin by performing sequence alignment analysis of the immunogen region across target species to predict potential cross-reactivity, noting that the antibody has documented reactivity with multiple plant species including Brassica, Solanum, and Glycine . Preliminary Western blot analysis should be conducted on each new species to confirm reactivity and determine the apparent molecular weight of the detected protein, which may vary slightly due to species-specific post-translational modifications. The optimization process should include titration of primary and secondary antibody concentrations, as optimal dilutions may differ between species due to variations in epitope accessibility or abundance. Similar to approaches used for other antibodies with broad cross-reactivity, researchers should validate specificity in each species through complementary techniques such as mass spectrometry identification of immunoprecipitated proteins or RNA interference to confirm the identity of detected bands . Extraction protocols may require species-specific modifications to account for differences in cell wall composition, secondary metabolites, or proteases that could affect protein yield or stability. When conducting comparative studies across species, researchers should normalize loading based on total chloroplast protein rather than total cellular protein to account for potential differences in chloroplast abundance. Additionally, researchers should consider evolutionary divergence in FBA gene family structure, as some species may have different numbers of FBA isoforms with varying degrees of homology to Arabidopsis FBA2.
FBA2 antibody-based detection and enzyme activity assays provide complementary information about aldolase function in plants, each with distinct advantages and limitations. Antibody-based detection using Western blotting or immunolocalization specifically quantifies FBA2 protein abundance and localization, allowing researchers to track changes in expression levels and subcellular distribution under different conditions. In contrast, spectrophotometric enzyme activity assays measure the functional capacity of all aldolase isoforms present in the sample by monitoring the conversion of fructose 1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Drawing from comparative analyses of other metabolic enzymes, researchers should note that protein abundance does not always correlate directly with enzyme activity due to post-translational modifications, allosteric regulation, or protein-protein interactions that may activate or inhibit the enzyme . Antibody-based methods offer higher specificity for distinguishing between different aldolase isoforms when using carefully validated antibodies, while activity assays provide functional information but cannot discriminate between contributions of different isoforms unless combined with genetic approaches or specific inhibitors. For comprehensive understanding of aldolase regulation, researchers should integrate both approaches along with transcript analysis to distinguish between transcriptional, translational, and post-translational regulation mechanisms. Additionally, in vitro activity assays may not accurately reflect in vivo enzyme behavior due to differences in substrate concentrations, cofactors, or protein-protein interactions that occur in the cellular environment.
Analyzing data from FBA2 antibody experiments in the context of photosynthetic metabolism requires integration of multiple factors that influence Calvin cycle function. Researchers should consider the diurnal regulation of photosynthetic enzymes, as FBA2 expression and activity may vary significantly throughout the day in response to light conditions. Normalization approaches are critical for meaningful comparisons, with options including total protein, specific chloroplast markers (such as RbcL), or housekeeping proteins, each with different implications for data interpretation. Similar to analysis approaches for other photosynthetic proteins, researchers should account for developmental gradients within leaves or other photosynthetic tissues, as enzyme abundance may vary between young and mature tissues . Environmental conditions during plant growth (light intensity, CO2 concentration, temperature, and nutrient availability) should be precisely documented and considered during analysis, as these factors significantly influence Calvin cycle regulation. When performing comparative analyses between genotypes or treatments, statistical approaches should account for both biological and technical variation, with mixed-effects models often appropriate for experimental designs with multiple sources of variation. For time-course experiments, researchers should consider using functional data analysis approaches that can capture dynamic patterns of change rather than simply comparing individual time points. Additionally, integration of FBA2 antibody data with measurements of photosynthetic parameters (CO2 assimilation rates, electron transport rates, or fluorescence parameters) can provide functional context for observed changes in protein abundance or localization.
Discrepancies between transcriptomic and FBA2 antibody-based protein data are common and provide valuable insights into post-transcriptional regulatory mechanisms. When encountering such discrepancies, researchers should first verify the reliability of both datasets through appropriate quality controls and replication. Time-lag effects between transcription and translation should be considered, particularly in time-course experiments, as transcript changes typically precede corresponding protein changes by several hours. Drawing from studies of other chloroplast proteins, researchers should examine potential post-transcriptional regulatory mechanisms including mRNA stability, translation efficiency, and protein turnover rates . Polysome profiling can assess translation efficiency of FBA2 transcripts under different conditions, while protein degradation assays using protein synthesis inhibitors can determine if changes in turnover rates contribute to observed discrepancies. Post-translational modifications such as phosphorylation, which commonly regulate Calvin cycle enzymes, should be investigated using phosphoproteomics approaches, as these modifications may affect protein stability without altering transcript levels. Protein localization changes, where total abundance remains constant but subcellular distribution shifts, can be detected through fractionation studies or immunolocalization but would not be reflected in transcript data. Correlation analysis across multiple experimental conditions can help identify patterns of co-regulation or divergence between transcript and protein levels. Additionally, mathematical modeling incorporating transcription, translation, and protein degradation rates can provide mechanistic explanations for observed discrepancies and generate testable hypotheses about regulatory mechanisms controlling FBA2 expression.
| Table 1: Cross-Reactivity of FBA2 Antibody with Plant Species |
|---|
| Plant Species |
| Arabidopsis thaliana |
| Brassica napus |
| Brassica rapa |
| Solanum lycopersicum |
| Gossypium raimondii |
| Vitis vinifera |
| Nicotiana tabacum |
| Solanum tuberosum |
| Glycine max |
| Medicago truncatula |
| Spinacia oleracea |
| Populus trichocarpa |
| Cucumis sativus |
| Table 2: Comparison of Methods for FBA2 Detection and Analysis |
|---|
| Method |
| Western blotting with FBA2 antibody |
| Immunolocalization |
| Enzyme activity assay |
| Co-immunoprecipitation |
| Transcript analysis (qRT-PCR) |
| Metabolomics |